Impaired production of BMP-15 and GDF-9 mature proteins derived from proproteins WITH mutations in the proregion

Molecular and Cellular Endocrinology

Volumn 328, Issue 1-2, 2010, Pages 1-7

  Inagaki, Kenichi ^a   Shimasaki, Shunichi ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

BMP; Dizygotic twins; GDF; Ovary; Premature ovarian failure; Primary ovarian insufficiency

Indexed keywords

BONE MORPHOGENETIC PROTEIN 15; GROWTH DIFFERENTIATION FACTOR 9; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOLOGICAL ACTIVITY; CANCER CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DIZYGOTIC TWINS; EMBRYO; FEMALE; GENE MUTATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY INSUFFICIENCY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEIN SYNTHESIS; RAT;

ANIMALS; BONE MORPHOGENETIC PROTEIN 15; CELLS, CULTURED; FEMALE; GROWTH DIFFERENTIATION FACTOR 9; HUMANS; MICE; POINT MUTATION; PRIMARY OVARIAN INSUFFICIENCY; PROTEIN BIOSYNTHESIS; PROTEIN MULTIMERIZATION; PROTEIN PRECURSORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN SORTING SIGNALS; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION, GENETIC;

EID: 77956343408     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.05.017     Document Type: Article

References (57)

1. Albright F., Smith P.H., Fraser R. A syndrome characterized by primary ovarian insufficiency and decreased stature. Am. J. Med. Sci. 1942, 204:625-648.
2. Bakalov V.K., Anasti J.N., Calis K.A., Vanderhoof V.H., Premkumar A., Chen S., Furmaniak J., Smith B.R., Merino M.J., Nelson L.M. Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46,XX spontaneous premature ovarian failure. Fertil. Steril. 2005, 84:958-965.
3. Chemaitilly W., Mertens A.C., Mitby P., Whitton J., Stovall M., Yasui Y., Robison L.L., Sklar C.A. Acute ovarian failure in the childhood cancer survivor study. J. Clin. Endocrinol. Metab. 2006, 91:1723-1728.
4. Conway G.S. Premature ovarian failure. Br. Med. Bull. 2000, 56:643-649.
5. Coulam C.B., Adamson S.C., Annegers J.F. Incidence of premature ovarian failure. Obstet. Gynecol. 1986, 67:604-606.
6. Davis G.H., McEwan J.C., Fennessy P.F., Dodds K.G., McNatty K.P., W.S.O. Infertility due to bilateral ovarian hypoplasia in sheep homozygous (FecXI FecXI) for the Inverdale prolificacy gene located on the X chromosome. Biol. Reprod. 1992, 46:636-640.
7. Di Pasquale E., Beck-Peccoz P., Persani L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am. J. Hum. Genet. 2004, 75:106-111.
8. Di Pasquale E., Rossetti R., Marozzi A., Bodega B., Borgato S., Cavallo L., Einaudi S., Radetti G., Russo G., Sacco M., Wasniewska M., Cole T., Beck-Peccoz P., Nelson L.M., Persani L. Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure. J. Clin. Endocrinol. Metab. 2006, 91:1976-1979.
9. Dixit H., Rao L.K., Padmalatha V., Kanakavalli M., Deenadayal M., Gupta N., Chakravarty B., Singh L. Mutational screening of the coding region of growth differentiation factor 9 gene in Indian women with ovarian failure. Menopause 2005, 12:749-754.
10. Dixit H., Rao L.K., Padmalatha V.V., Kanakavalli M., Deenadayal M., Gupta N., Chakrabarty B., Singh L. Missense mutations in the BMP15 gene are associated with ovarian failure. Hum. Genet. 2006, 119:408-415.
11. Driancourt M.A., Reynaud K., Cortvrindt R., Smitz J. Roles of KIT and KIT LIGAND in ovarian function. Rev. Reprod. 2000, 5:143-152.
12. Dube J.L., Wang P., Elvin J., Lyons K.M., Celeste A.J., Matzuk M.M. The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes. Mol. Endocrinol. 1998, 12:1809-1817.
13. Galloway S.M., McNatty K.P., Cambridge L.M., Laitinen M.P.E., Juengel J.L., Jokiranta T.S., McLaren R.J., Luiro K., Dodds K.G., Montgomery G.W., Beattie A.E., Davis G.H., Ritvos O. Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat. Genet. 2000, 25:279-283.
14. Hanrahan J.P., Gregan S.M., Mulsant P., Mullen M., Davis G.H., Powell R., Galloway S.M. Mutations in the genes for oocyte-derived growth factors GDF9 and BMP15 are associated with both increased ovulation rate and sterility in Cambridge and Belclare sheep (Ovis aries). Biol. Reprod. 2004, 70:900-909.
15. Hashimoto O., Moore R.K., Shimasaki S. Posttranslational processing of mouse and human BMP-15: potential implication in the determination of ovulation quota. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:5426-5431.
16. Hoek A., Schoemaker J., Drexhage H.A. Premature ovarian failure and ovarian autoimmunity. Endocr. Rev. 1997, 18:107-134.
17. Hogan B.L. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 1996, 10:1580-1594.
18. Jick H., Porter J., Morrison A.S. Relation between smoking and age of natural menopause. Lancet 1977, 1:1354-1355.
19. Juengel J.L., Hudson N.L., Heath D.A., Smith P., Reader K.L., Lawrence S.B., O'Connell A.R., Laitinen M.P.E., Cranfield M., Groome N.P., Ritvos O., McNatty K.P. Growth differentiation factor-9 and bone morphogenetic protein 15 are essential for ovarian follicular development in sheep. Biol. Reprod. 2002, 67:1777-1789.
20. Juengel J.L., Hudson N.L., Whiting L., McNatty K.P. Effects of immunization against bone morphogenetic protein 15 and growth differentiation factor 9 on ovulation rate, fertilization, and pregnancy in ewes. Biol. Reprod. 2004, 70:557-561.
21. Kovanci E., Rohozinski J., Simpson J.L., Heard M.J., Bishop C.E., Carson S.A. Growth differentiating factor-9 mutations may be associated with premature ovarian failure. Fertil. Steril. 2007, 87:143-146.
22. Laissue P., Christin-Maitre S., Touraine P., Kuttenn F., Ritvos O., Aittomaki K., Bourcigaux N., Jacquesson L., Bouchard P., Frydman R., Dewailly D., Reyss A.-C., Jeffery L., Bachelot A., Massin N., Fellous M., Veitia R.A. Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure. Eur. J. Endocrinol. 2006, 154:739-744.
23. Laissue P., Vinci G., Veitia R.A., Fellous M. Recent advances in the study of genes involved in non-syndromic premature ovarian failure. Mol. Cell. Endocrinol. 2008, 282:101-111.
24. Laitinen M., Vuojolainen K., Jaatinen R., Ketola I., Aaltonen J., Lehtonen E., Heikinheimo M., Ritvos O. A novel growth differentiation factor-9 (GDF-9) related factor is co-expressed with GDF-9 in mouse oocytes during folliculogenesis. Mech. Dev. 1998, 78:135-140.
25. Lass A. The fertility potential of women with a single ovary. Hum. Reprod. Update 1999, 5:546-550.
26. Ledig S., Ropke A., Haeusler G., Hinney B., Wieacker P. BMP15 mutations in XX gonadal dysgenesis and premature ovarian failure. Am. J. Obstet. Gynecol. 2008, 198(84):e81-85.
27. Li Q., Rajanahally S., Edson M.A., Matzuk M.M. Stable expression and characterization of N-terminal tagged recombinant human bone morphogenetic protein 15. Mol. Hum. Reprod. 2009, 15:779-788.
28. Liao W.X., Moore R.K., Otsuka F., Shimasaki S. Effect of intracellular interactions on the processing and secretion of bone morphogenetic protein-15 (BMP-15) and growth and differentiation factor-9: implication of the aberrant ovarian phenotype of BMP-15 mutant sheep. J. Biol. Chem. 2003, 278:3713-3719.
29. Liao W.X., Moore R.K., Shimasaki S. Functional and molecular characterization of naturally occurring mutations in the oocyte-secreted factors BMP-15 and GDF-9. J. Biol. Chem. 2004, 279:17391-17396.
30. Marozzi A., Manfredini E., Tibiletti M.G., Furlan D., Villa N., Vegetti W., Crosignani P.G., Ginelli E., Meneveri R., Dalpra L. Molecular definition of Xq common-deleted region in patients affected by premature ovarian failure. Hum. Genet. 2000, 107:304-311.
31. Martin N.G., Healey S.C., Pangan T.S., Heath A.C., Turner G. Do mothers of dizygotic twins have earlier menopause? A role for fragile X?. Am. J. Med. Genet. 1997, 69:114-116.
32. Massagué J., Attisano L., Wrana J.L. The TGF-β family and its composite receptors. Trends Cell. Biol. 1994, 4:172-178.
33. McMahon H.E., Sharma S., Shimasaki S. Phosphorylation of bone morphogenetic protein-15 and growth and differentiation factor-9 plays a critical role in determining agonistic or antagonistic functions. Endocrinology 2008, 149:812-817.
34. McNatty K.P., Heath D.A., Hudson N.L., Lun S., Juengel J.L., Moore L.G. Gonadotrophin-responsiveness of granulosa cells from bone morphogenetic protein 15 heterozygous mutant sheep. Reproduction 2009, 138:545-551.
35. McNatty K.P., Smith P., Moore L.G., Reader K., Lun S., Hanrahan J.P., Groome N.P., Laitinen M., Ritvos O., Juengel J.L. Oocyte-expressed genes affecting ovulation rate. Mol. Cell. Endocrinol. 2005, 234:57-66.
36. Meirow D. Reproduction post-chemotherapy in young cancer patients. Mol. Cell. Endocrinol. 2000, 169:123-131.
37. Montgomery G.W., McNatty K.P., Davis G.H. Physiology and molecular genetics of mutations that increase ovulation rate in sheep. Endocr. Rev. 1992, 13:309-328.
38. Mottershead D.G., Pulkki M.M., Muggalla P., Pasternack A., Tolonen M., Myllymaa S., Korchynskyi O., Nishi Y., Yanase T., Lun S., Juengel J.L., Laitinen M., Ritvos O. Characterization of recombinant human growth differentiation factor-9 signaling in ovarian granulosa cells. Mol. Cell. Endocrinol. 2008, 283:58-67.
39. Nelson L.M., Anasti J.N., Kimzey L.M., Defensor R.A., Lipetz K.J., White B.J., Shawker T.H., Merino M.J. Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J. Clin. Endocrinol. Metab. 1994, 79:1470-1475.
40. Otsuka F., Shimasaki S. A negative feedback system between oocyte bone morphogenetic protein 15 and granulosa cell kit ligand: its role in regulating granulosa cell mitosis. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:8060-8065.
41. Otsuka F., Yamamoto S., Erickson G.F., Shimasaki S. Bone morphogenetic protein-15 inhibits follicle-stimulating hormone (FSH) action by suppressing FSH receptor expression. J. Biol. Chem. 2001, 276:11387-11392.
42. Otsuka F., Yao Z., Lee T.H., Yamamoto S., Erickson G.F., Shimasaki S. Bone morphogenetic protein-15: identification of target cells and biological functions. J. Biol. Chem. 2000, 275:39523-39528.
43. Palmer J.S., Zhao Z.Z., Hoekstra C., Hayward N.K., Webb P.M., Whiteman D.C., Martin N.G., Boomsma D.I., Duffy D.L., Montgomery G.W. Novel variants in growth differentiation factor 9 in mothers of dizygotic twins. J. Clin. Endocrinol. Metab. 2006, 91:4713-4716.
44. Rebar R.W., Connolly H.V. Clinical features of young women with hypergonadotropic amenorrhea. Fertil. Steril. 1990, 53:804-810.
45. Rebar R.W., Erickson G.F., Yen S.S. Idiopathic premature ovarian failure: clinical and endocrine characteristics. Fertil. Steril. 1982, 37:35-41.
46. Rossetti R., Di Pasquale E., Marozzi A., Bione S., Toniolo D., Grammatico P., Nelson L.M., Beck-Peccoz P., Persani L. BMP15 mutations associated with primary ovarian insufficiency cause a defective production of bioactive protein. Hum. Mutat. 2009, 30:804-810.
47. Shackell G.H., Hudson N.L., Heath D.A., Lun S., Shaw L., Condell L., Blay L.R., McNatty K.P. Plasma gonadotropin concentrations and ovarian characteristics in Inverdale ewes that are heterozygous for a major gene (FecX1) on the X chromosome that influences ovulation rate. Biol. Reprod. 1993, 48:1150-1156.
48. Shimasaki S., Moore R.K., Otsuka F., Erickson G.F. The bone morphogenetic protein system in mammalian reproduction. Endocr. Rev. 2004, 25:72-101.
49. Simpson J.L. Genetic and phenotypic heterogeneity in ovarian failure: overview of selected candidate genes. Ann. N. Y. Acad. Sci. 2008, 1135:146-154.
50. Simpson J.L., Rajkovic A. Ovarian differentiation and gonadal failure. Am. J. Med. Genet. 1999, 89:186-200.
51. Skillern A., Rajkovic A. Recent developments in identifying genetic determinants of premature ovarian failure. Sex. Dev. 2008, 2:228-243.
52. Sklar C.A., Mertens A.C., Mitby P., Whitton J., Stovall M., Kasper C., Mulder J., Green D., Nicholson H.S., Yasui Y., Robison L.L. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J. Natl. Cancer Inst. 2006, 98:890-896.
53. Takebayashi K., Takakura K., Wang H.Q., Kimura F., Kasahara K., Noda Y. Mutation analysis of the growth differentiation factor-9 and -9B genes in patients with premature ovarian failure and polycystic ovary syndrome. Fertil. Steril. 2000, 74:976-979.
54. Taylor A.E., Adams J.M., Mulder J.E., Martin K.A., Sluss P.M., Crowley W.F. A randomized, controlled trial of estradiol replacement therapy in women with hypergonadotropic amenorrhea. J. Clin. Endocrinol. Metab. 1996, 81:3615-3621.
55. Zhao H., Qin Y., Kovanci E., Simpson J.L., Chen Z.-J., Rajkovic A. Analyses of GDF9 mutation in 100 Chinese women with premature ovarian failure. Fertil. Steril. 2007, 88:1474-1476.
56. Zhao Z.Z., Painter J.N., Palmer J.S., Webb P.M., Hayward N.K., Whiteman D.C., Boomsma D.I., Martin N.G., Duffy D.L., Montgomery G.W. Variation in bone morphogenetic protein 15 is not associated with spontaneous human dizygotic twinning. Hum. Reprod. 2008, 23:2372-2379.
57. Zinn A.R., Tonk V.S., Chen Z., Flejter W.L., Gardner H.A., Guerra R., Kushner H., Schwartz S., Sybert V.P., Van Dyke D.L., Ross J.L. Evidence for a Turner syndrome locus or loci at Xp11.2-p22.1. Am. J. Hum. Genet 1998, 63:1757-1766.